PFIZER INC Marketable Securities
PFIZER INC (PFE) had Marketable Securities of $32.22 billion as of 2011-04-03, per its 10-Q filed 2011-05-12.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2011-05-12
- 2011-04-03: Marketable Securities $32.22B.
- 2010-12-31: Marketable Securities $35.50B.
- 2010-10-03: Marketable Securities $30.60B.
- 2010-07-04: Marketable Securities $27.26B.
| Period end | Marketable Securities |
|---|---|
| 2011-04-03 | $32.22B 10-Q · filed 2011-05-12 |
| 2010-12-31 | $35.50B 10-K · filed 2011-02-28 |
| 2010-10-03 | $30.60B 10-Q · filed 2010-11-12 |
| 2010-07-04 | $27.26B 10-Q · filed 2010-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |